TSE:4503 (Japan)  
Astellas Pharma Inc logo

Astellas Pharma Inc

円 1904.50 (-1.86%) Sep 22
P/E:
28.41
P/B:
2.38
Market Cap:
円 3.48T ($ 24.27B)
Enterprise V:
円 3.14T ($ 21.92B)
Volume:
6.44M
Avg Vol (2M):
4.27M
Also Trade In:
Volume:
6.44M
Market Cap 円:
3.48T
Market Cap $:
24.27B
PE Ratio:
28.41
Avg Vol (2-Month):
4.27M
Enterprise Value 円:
3.14T
Enterprise Value $:
21.92B
PB Ratio:
2.38
GF Score:
Year:
Embed
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website Sources Stock Report
Dataset
Financial Download

Business Description

Description
Astellas Pharma Inc is a drug manufacturing company that sells pharmaceutical products across the globe. The vast majority of the company's revenue is derived from Japanese markets, followed by the Americas. Royalty income makes up a small percentage of Astellas' overall sales. Its largest therapeutic area by sales composition is oncology, followed by urology and transplantation. The company uses mergers and acquisitions as part of its long-term growth strategy. Astellas enters into strategic partnerships and licensing agreements to strengthen its commercialization platforms.

Financials

TSE:4503's 30-Y Financials

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
To

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Valuation Box

Year:
Embed

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil 円) 1,296,163
EPS (TTM) (円) 67.04
Beta 0.59
Volatility % 13.38
14-Day RSI 32.85
14-Day ATR (円) 34.429717
20-Day SMA (円) 1983.55
12-1 Month Momentum % 9.55
52-Week Range (円) 1739 - 2205
Shares Outstanding (Mil) 1,827.07

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 8
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Astellas Pharma Inc Filings

Document Form Filing Date
No Filing Data

Astellas Pharma Inc Analysis

Share your research